Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Fouassier

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 8, 2021
Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout miceEster Gonzalez-Sanchez, Haquima El Mourabit, Marion Jager, et al.
Hepatology (Baltimore, Md.)|June 22, 2013
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptorAudrey Clapéron, Martine Mergey, Lynda Aoudjehane, et al.
Hepatology (Baltimore, Md.)|July 23, 2021
Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine SignalingCindy Lobe, Marie Vallette, Ander Arbelaiz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2019
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistanceLaura Fouassier, Marco Marzioni, Marta B Afonso, et al.
Free Radical Biology & Medicine|July 15, 2015
Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cellsThanh Huong Nguyen Ho-Bouldoires, Audrey Clapéron, Martine Mergey, et al.
JHEP Reports : Innovation in Hepatology|April 23, 2026
A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reactionMariana Amaral Raposo, Haquima El Mourabit, Wenrui Gao, et al.
Elife|June 9, 2021
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatmentAlba Nicolas-Boluda, Javier Vaquero, Lene Vimeux, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 7, 2023
Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinomaVanessa Bou Malham, Nassima Benzoubir, Javier Vaquero, et al.
The American Journal of Pathology|November 8, 2025
Loss of Aquaporin-1 in Tumor Cells Fosters Intrahepatic Cholangiocarcinoma ProgressionCésar I Gaspari, Carine Beaupere, Seth Richard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2026
Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinomaEster Gonzalez-Sanchez, Marie Vallette, Lucia Garcia-Collado, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 8, 2021
Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout miceEster Gonzalez-Sanchez, Haquima El Mourabit, Marion Jager, et al.
Hepatology (Baltimore, Md.)|June 22, 2013
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptorAudrey Clapéron, Martine Mergey, Lynda Aoudjehane, et al.
Hepatology (Baltimore, Md.)|July 23, 2021
Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine SignalingCindy Lobe, Marie Vallette, Ander Arbelaiz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2019
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistanceLaura Fouassier, Marco Marzioni, Marta B Afonso, et al.
Free Radical Biology & Medicine|July 15, 2015
Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cellsThanh Huong Nguyen Ho-Bouldoires, Audrey Clapéron, Martine Mergey, et al.
JHEP Reports : Innovation in Hepatology|April 23, 2026
A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reactionMariana Amaral Raposo, Haquima El Mourabit, Wenrui Gao, et al.
Elife|June 9, 2021
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatmentAlba Nicolas-Boluda, Javier Vaquero, Lene Vimeux, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 7, 2023
Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinomaVanessa Bou Malham, Nassima Benzoubir, Javier Vaquero, et al.
The American Journal of Pathology|November 8, 2025
Loss of Aquaporin-1 in Tumor Cells Fosters Intrahepatic Cholangiocarcinoma ProgressionCésar I Gaspari, Carine Beaupere, Seth Richard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2026
Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinomaEster Gonzalez-Sanchez, Marie Vallette, Lucia Garcia-Collado, et al.
Pageof 5